Evidence map›Paper›PMID 23716465›Full record

ArticleBirth defects research. Part A, Clinical and molecular teratology2013

Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.

Mayura U Shinde, Ann M Vuong, Jean D Brender, Martha M Werler, Katherine E Kelley, John C Huber, Joseph R Sharkey, Qi Zheng, Lucina Suarez, Peter H Langlois and 4 more

Open access · greenAbstract read
In one paragraph

Article in Birth defects research. Part A, Clinical and molecular teratology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Mayura U ShindeTexas A&M Health Science Center, School of Rural Public Health, College Station, Texas 77843-1266, USA. shinde@srph.tamhsc.edu
Ann M Vuong
Jean D Brender
Martha M Werler
Katherine E Kelley
John C Huber
Joseph R Sharkey
Qi Zheng
Lucina Suarez
Peter H Langlois
Mark A Canfield
Paul A Romitti
Sadia Malik
National Birth Defects Prevention Study
Texas A&M Health Science Center · USTexas Department of State Health Services · USBoston University · USUniversity of Arkansas for Medical Sciences · USUniversity of Iowa · US

Funding

Texas Center for Birth Defects Research and PreventionU01DD000494 · DD · TEXAS STATE DEPT OF HEALTH SERVICES · PI CANFIELD, MARK A · 2009 to 2013
$3.9M
Iowa Center for Birth Defects Research and Prevention (ICBDRP)U01DD000492 · DD · UNIVERSITY OF IOWA · PI ROMITTI, PAUL A · 2009 to 2013
$3.9M
Nitrates, Nitrites, and Nitrosatable Drugs and Risk of Selected Birth DefectsR01ES015634 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BRENDER, JEAN DIANE · 2007 to 2010
$1.7M
NCBDD CDC HHS U01 DD000492NCBDD CDC HHS U01 DD000494NCBDD CDC HHS U01DD000494NCBDD CDC HHS U01 DD001035NIEHS NIH HHS 3R01ES015634-03S1NIEHS NIH HHS 5R01ES015634NIEHS NIH HHS R01 ES015634
6 · The paper itself

Abstract

unlabelledNitrosatable drugs, such as secondary or tertiary amines and amides react with nitrite in an acidic environment to form N-nitroso compounds, teratogens in animal models. Vitamin C is a known nitrosation inhibitor.

methodsUsing data from the National Birth Defects Prevention Study, we assessed nitrosatable drug exposure and vitamin C intake during the first trimester among 11,606 case-mothers of infants with oral clefts, limb deficiencies (LDs), or congenital heart defects and 6807 control-mothers of infants without major birth defects during 1997-2005. Daily intake of vitamin C was estimated from maternal interviews that elicited information about supplement use and dietary intake.

resultsWith no reported use of nitrosatable drugs as the referent group, a lower odds ratio (OR) was observed for transverse LDs among births to mothers exposed to secondary amine drugs and daily vitamin C supplementation (adjusted odds ratio [aOR] 1.2, 95% confidence interval [CI] 0.83-1.8) compared with women taking these drugs and no supplementation (aOR 2.7, 95% CI 1.5-4.6). The OR for longitudinal LDs associated with secondary amine exposure was lower with daily dietary vitamin C intake ≥85 mg (aOR 1.2, 95% CI 0.68-2.0) compared with <85 mg (aOR 1.9, 95% CI 1.2-3.1). Daily vitamin C supplementation in combination with higher dietary vitamin C intake reduced associations between nitrosatable drug exposures and limb deficiencies and atrial septal defects not otherwise specified.

conclusionPrenatal dietary and vitamin C supplement intake may diminish the association between nitrosatable drug exposure during pregnancy and selected birth defects.

Indexed as

Ascorbic AcidBrainCase-Control StudiesCleft LipCleft PalateDietary SupplementsFemaleHeart Defects, CongenitalHumansLimb Deformities, CongenitalMaternal ExposureNitrosationNitroso CompoundsPregnancyAscorbic AcidNitroso Compoundsbirth defectsdietary vitamin Cheart defectslimb deficienciesnitrosatable drugoral cleftsvitamin C

Identifiers

PMID23716465
PMCPMC5893146
OpenAlexW2129045540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.